Hasil Pencarian - Atul Deodhar
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 20 hasil dari 50
- Ke Halaman Berikutnya
-
1
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review oleh Philip Mease, Atul Deodhar
Diterbitkan 2022-03-01Dapatkan teks lengkap
Artikel -
2
Human Leukocyte Antigen B27‐Negative Axial Spondyloarthritis: What Do We Know? oleh Atul Deodhar, Tejpal Gill, Marina Magrey
Diterbitkan 2023-07-01Dapatkan teks lengkap
Artikel -
3
An update on the management of axial spondyloarthritis for sports medicine professionals oleh Abhijeet Danve, Marina Magrey, Atul Deodhar
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
4
-
5
-
6
IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis oleh Atul Deodhar, Dirk Elewaut, Dominique Baeten, Xenofon Baraliakos
Diterbitkan 2015-07-01Dapatkan teks lengkap
Artikel -
7
-
8
-
9
-
10
Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis oleh Victoria Navarro-Compán, Atul Deodhar, Rachid Bahiri, Andrew G. Bushmakin, Joseph C. Cappelleri, Jihane Rammaoui
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
11
-
12
Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease‐Modifying Antirheumatic Drug Use: A Post Hoc Analysis oleh Atul Deodhar, Helena Marzo‐Ortega, Joseph Wu, Cunshan Wang, Oluwaseyi Dina, Keith S. Kanik, Lara Fallon, Lianne S. Gensler
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel -
13
The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2 oleh Atul Deodhar, Dafna Gladman, Rebecca Bolce, David Sandoval, So Young Park, Soyi Liu Leage, Peter Nash, Denis Poddubnyy
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
14
Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST oleh Maxime Dougados, Atul Deodhar, Jürgen Braun, Uta Kiltz, Chen-Yen Lin, Tetsuya Tomita, Rebecca Bolce, Jessica Walsh, David Sandoval
Diterbitkan 2022-12-01Dapatkan teks lengkap
Artikel -
15
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status oleh Atul Deodhar, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Lianne Gensler, Walter Maksymowych, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
16
Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks oleh Atul Deodhar, Philip Mease, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Steven Lauzon, Ann Leung, Victoria Navarro-Compán
Diterbitkan 2021-09-01Dapatkan teks lengkap
Artikel -
17
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study oleh Atul Deodhar, Vibeke Strand, Rieke Alten, P G Conaghan, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl
Diterbitkan 2020-09-01Dapatkan teks lengkap
Artikel -
18
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data oleh Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
19
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis oleh Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D. Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar
Diterbitkan 2023-02-01Dapatkan teks lengkap
Artikel -
20
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis oleh M. Elaine Husni, Atul Deodhar, Sergio Schwartzman, Soumya D. Chakravarty, Elizabeth C. Hsia, Jocelyn H. Leu, Yiying Zhou, Kim H. Lo, Arthur Kavanaugh
Diterbitkan 2022-03-01Dapatkan teks lengkap
Artikel